Innovative Research Award
Xiaoyong Wang
Nanjing University
| Researcher Information |
| Affiliation |
Nanjing University |
| Country |
China |
| Scopus ID |
57194713052 |
| Documents |
221 |
| Citations |
11,435 |
| h-index |
53 |
| Subject Area |
Anticancer Drugs |
| Event |
World Skincare Innovation Awards |
The Innovative Research Award evaluation recognizes the scholarly achievements and scientific contributions of Xiaoyong Wang of Nanjing University. His publication portfolio demonstrates sustained research productivity, significant citation impact, and notable influence within the field of anticancer drug discovery and related biomedical sciences. With more than two hundred indexed publications and an extensive citation record, his research has contributed to the advancement of therapeutic strategies, translational medicine, and pharmaceutical innovation.[1]
Abstract
This article presents an academic assessment of Xiaoyong Wang in relation to the Innovative Research Award. The evaluation considers publication productivity, citation performance, scholarly influence, and research relevance within the domain of anticancer drug development. Quantitative bibliometric indicators, including publication count, citation volume, and h-index, indicate a sustained and influential research trajectory that aligns with internationally recognized standards of scientific excellence.[1]
Keywords
Anticancer Drugs, Biomedical Research, Drug Discovery, Pharmaceutical Sciences, Translational Medicine, Citation Impact, Research Excellence, Scientific Innovation.
Introduction
Academic recognition programs evaluate researchers based on measurable scientific contributions, influence within their discipline, and the broader significance of their work. Xiaoyong Wang has established a substantial scholarly record through research focused on anticancer therapeutics and related biomedical applications. His work has been disseminated through internationally indexed publications and has attracted considerable scholarly attention, reflecting both relevance and scientific quality.[1][2]
Research Profile
- Researcher: Xiaoyong Wang
- Institution: Nanjing University
- Country: China
- Scopus Documents: 221
- Total Citations: 11,435
- h-index: 53
- Primary Subject Area: Anticancer Drugs
The available bibliometric indicators demonstrate extensive publication activity combined with a strong citation footprint. Such metrics are frequently used as indicators of scholarly influence, research visibility, and sustained academic engagement within a specialized research field.[1]
Research Contributions
Xiaoyong Wang's research contributions span areas associated with anticancer drug discovery, therapeutic development, molecular mechanisms of disease, and translational biomedical science. His publications have contributed to scientific understanding of emerging therapeutic approaches and have supported ongoing developments in pharmaceutical research.[3]
- Development of innovative therapeutic strategies.
- Investigation of molecular targets associated with cancer treatment.
- Contribution to interdisciplinary biomedical collaborations.
- Publication of highly cited research articles in peer-reviewed journals.
Publications
The researcher has authored or co-authored 221 indexed documents according to Scopus records. The publication portfolio encompasses original research articles, reviews, and collaborative studies that contribute to the advancement of biomedical and pharmaceutical knowledge. The breadth and consistency of publication activity demonstrate long-term engagement with high-impact scientific research.[1]
Research Impact
Research impact may be assessed through citation-based indicators, scholarly visibility, and influence on subsequent investigations. With 11,435 citations and an h-index of 53, Xiaoyong Wang's work demonstrates significant academic reach and sustained recognition by the international research community. These indicators suggest that numerous publications have achieved substantial visibility and have contributed to ongoing scientific discourse.[1][4]
Award Suitability
Based on the available bibliometric evidence, publication productivity, citation performance, and research relevance, Xiaoyong Wang demonstrates characteristics commonly associated with candidates considered for international research recognition. The scale of scholarly output, combined with a strong citation record and sustained contribution to anticancer drug research, supports consideration for the Innovative Research Award presented through the World Skincare Innovation Awards.[1][5]
Conclusion
Xiaoyong Wang's academic profile reflects substantial scholarly achievement characterized by a large body of peer-reviewed research, extensive citation impact, and sustained contribution to the advancement of anticancer therapeutics. The available evidence indicates a researcher whose work has achieved notable visibility and influence within the scientific community. These accomplishments align with the objectives of academic recognition programs that seek to acknowledge impactful and innovative research contributions.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Xiaoyong Wang, Author ID 57194713052. Scopus.
Scopus Author Profile
- Nanjing University. (n.d.). Faculty and Research Information.
https://www.nju.edu.cn/
- Nature Reviews Drug Discovery. (2018). Advances in Anticancer Drug Discovery.
DOI:https://doi.org/10.1038/nrd.2017.243
- Hirsch, J. E. (2005). An Index to Quantify an Individual's Scientific Research Output.
DOI:https://doi.org/10.1073/pnas.0507655102
- World Skincare Innovation Awards. (n.d.). Award Program Information.
https://skincareaward.com/